Department for Research, Studies, Assessment and Statistics (DREES), French Ministry of Health, Paris, France.
Service de Médecine Intensive - Réanimation, Hôpital du Kremlin Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, France.
J Infect. 2023 Aug;87(2):120-127. doi: 10.1016/j.jinf.2023.05.011. Epub 2023 May 16.
Prior to the coronavirus disease 2019 (COVID-19) pandemic, influenza was the most frequent cause of viral respiratory pneumonia requiring intensive care unit (ICU) admission. Few studies have compared the characteristics and outcomes of critically ill patients with COVID-19 and influenza.
This was a French nationwide study comparing COVID-19 (March 1, 2020-June 30, 2021) and influenza patients (January 1, 2014-December 31, 2019) admitted to an ICU during pre-vaccination era. Primary outcome was in-hospital death. Secondary outcome was need for mechanical ventilation.
105,979 COVID-19 patients were compared to 18,763 influenza patients. Critically ill patients with COVID-19 were more likely to be men with more comorbidities. Patients with influenza required more invasive mechanical ventilation (47 vs. 34%, p < 0·001), vasopressors (40% vs. 27, p < 0·001) and renal-replacement therapy (22 vs. 7%, p < 0·001). Hospital mortality was 25% and 21% (p < 0·001) in patients with COVID-19 and influenza, respectively. In the subgroup of patients receiving invasive mechanical ventilation, ICU length of stay was significantly longer in patients with COVID-19 (18 [10-32] vs. 15 [8-26] days, p < 0·001). Adjusting for age, gender, comorbidities, and modified SAPS II score, in-hospital death was higher in COVID-19 patients (adjusted sub-distribution hazard ratio [aSHR]=1.69; 95%CI=1.63-1.75) compared with influenza patients. COVID-19 was also associated with less invasive mechanical ventilation (aSHR=0.87; 95%CI=0.85-0.89) and a higher likelihood of death without invasive mechanical ventilation (aSHR=2.40; 95%CI=2.24-2.57).
Despite younger age and lower SAPS II score, critically ill COVID-19 patients had a longer hospital stay and higher mortality than patients with influenza.
在 2019 年冠状病毒病(COVID-19)大流行之前,流感是导致需要入住重症监护病房(ICU)的病毒性呼吸道肺炎的最常见原因。很少有研究比较过 COVID-19 和流感重症患者的特征和结局。
这是一项法国全国性研究,比较了 COVID-19(2020 年 3 月 1 日至 2021 年 6 月 30 日)和流感患者(2014 年 1 月 1 日至 2019 年 12 月 31 日)在疫苗接种前时期入住 ICU 的情况。主要结局是院内死亡。次要结局是需要机械通气。
共比较了 105979 例 COVID-19 患者和 18763 例流感患者。COVID-19 重症患者更可能是男性,且合并症更多。流感患者需要更多的有创机械通气(47%比 34%,p<0·001)、血管加压药(40%比 27%,p<0·001)和肾脏替代治疗(22%比 7%,p<0·001)。COVID-19 和流感患者的院内死亡率分别为 25%和 21%(p<0·001)。在接受有创机械通气的患者亚组中,COVID-19 患者 ICU 住院时间明显更长(18[10-32]天比 15[8-26]天,p<0·001)。调整年龄、性别、合并症和改良 SAPS II 评分后,COVID-19 患者院内死亡率更高(调整后的亚分布风险比[aSHR]=1.69;95%CI=1.63-1.75)。与流感患者相比,COVID-19 还与更少的有创机械通气(aSHR=0.87;95%CI=0.85-0.89)和更高的无有创机械通气死亡概率(aSHR=2.40;95%CI=2.24-2.57)相关。
尽管 COVID-19 患者年龄较小,SAPS II 评分较低,但住院时间和死亡率均高于流感患者。